Sleep apnea, heart failure, and pulmonary hypertension

Current Heart Failure Reports

Volumn 10, Issue 4, 2013, Pages 315-320

  Javaheri, Sogol ^a   Javaheri, Shahrokh ^b   Javaheri, Ali ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Heart failure; Pulmonary hypertension; Sleep; Sleep apnea

Indexed keywords

APNEA HYPOPNEA INDEX; ARTERIAL PRESSURE; ARTICLE; DISEASE ASSOCIATION; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART RATE; HOSPITALIZATION; HUMAN; LUNG BLOOD VESSEL; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; OXIDATIVE STRESS; OXYGEN DESATURATION; OXYGEN SATURATION; PARASYMPATHETIC TONE; PULMONARY HYPERTENSION; PULSE OXIMETRY; REOXYGENATION; SLEEP DISORDERED BREATHING; SURVIVAL; SWAN GANZ CATHETER; SYMPATHETIC TONE;

HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; PREVALENCE; SLEEP APNEA SYNDROMES; STROKE VOLUME;

EID: 84888071812     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-013-0167-3     Document Type: Article

References (44)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2012 update: a report from the American heart association. Circulation. 2012;125:e2-220.
2. •• Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO. Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol. 2013;61:391-403. This paper highlights important strategies to minimizing rehospitalization for heart failure, which approahces 30 % within 60 to 90 days after discharge.
3. •• Javaheri S. Sleep-related breathing disorders in heart failure. In: Doulgas L, Mann F, editors. A companion to braunwald's heart disease. Philadelphia: WB Saunders; 2010. p. 471-87. This chapter discusses fundamental pathophysiology of sleep-related breathing disorders.
4. Herrscher TE, Akre H, Overland B, Sandvik L, Westheim AS. High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J Card Fail. 2011;17:420-5.
5. Bradley TD, Floras JS. Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation. 2003;107:1671-8.
6. Garcia-Touchard A, Somers VK, Olson LJ, Caples SM. Central sleep apnea: implications for congestive heart failure. Chest. 2008;133:1495-504.
7. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003;348:1233-41.
8. •• Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the canadian continuous positive airway pressure for patients with central sleep apnea and heart failure trial (canpap). Circulation. 2007;115:3173-80. This post-hoc analysis of the CANPAP trial demonstrated that patients who responded to CPAP therapy had improved survival, raising the hypothesis that adequate treatment of central sleep apnea can improve survival in heart failure.
9. •• Javaheri S, Caref EB, Chen E, Tong KB, Abraham WT. Sleep apnea testing and outcomes in a large cohort of medicare beneficiaries with newly diagnosed heart failure. Am J Respir Crit Care Med. 2011;183:539-46. Despite the high prevalence of sleep apnea in heart failure, only 4 % of incident cases of heart failure were referred for sleep studies. Of the small percentage of patients referred and tested, those who were treated demonstrated improved survival.
10. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation. 1990;81:700-2.
11. Bonsignore MR, Marrone O, Insalaco G, Bonsignore G. The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenic mechanisms. Eur Respir J. 1994;7:786-805.
12. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol. 2006;106:21-8.
13. Oldenburg O, Lamp B, Topfer V, Faber L, Teschler H, Horstkotte D. Prevalence of sleep-related breathing disorders in ischemic and non-ischemic heart failure. Dtsch Med Wochenschr. 2007;132:661-6.
14. Zhao ZH, Sullivan C, Liu ZH, Luo Q, Xiong CM, Ni XH, et al. Prevalence and clinical characteristics of sleep apnea in chinese patients with heart failure. Int J Cardiol. 2007;118:122-3.
15. Ferreira S, Marinho A, Patacho M, Santa-Clara E, Carrondo C, Winck J, et al. Prevalence and characteristics of sleep apnoea in patients with stable heart failure: results from a heart failure clinic. BMC Pulm Med. 2010;10:9.
16. •• Bitter T, Faber L, Hering D, Langer C, Horstkotte D, Oldenburg O. Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail. 2009;11:602-8. This paper established that the prevalence of sleep apnea in heart failure with preserved ejection fraction patients is probably as high as heart failure with reduced ejection fraction patients.
17. Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol. 2007;49:2028-34.
18. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49:1625-31.
19. Sasayama S, Izumi T, Seino Y, Ueshima K, Asanoi H. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration. Circ J. 2006;70:1-7.
20. Khayat R, Abraham W, Patt B, Brinkman V, Wannemacher J, Porter K, et al. Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. J Card Fail. 2012;18:534-40.
21. •• Damy T, Margarit L, Noroc A, Bodez D, Guendouz S, Boyer L, et al. Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail. 2012;14:1009-19. This paper demonstrates that in heart failure patients, SDB is associated with worse outcomes but that treatment with PAP therapy improves prognosis.
22. Kasai T, Narui K, Dohi T, Yanagisawa N, Ishiwata S, Ohno M, et al. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest. 2008;133:690-6.
23. •• Javaheri S, Shukla R, Wexler L. Association of smoking, sleep apnea, and plasma alkalosis with nocturnal ventricular arrhythmias in men with systolic heart failure. Chest. 2012;141:1449-56. In Veterans with systolic heart failure, multiple regression analysis showed four variables associated with ventricular tachycardia. The authors speculate that effective treatment of sleep disordered breathing and smoking cessation may decrease the incidence of sudden cardiac death.
24. Lafitte S, Pillois X, Reant P, Picard F, Arsac F, Dijos M, et al. Estimation of pulmonary pressures and diagnosis of pulmonary hypertension by doppler echocardiography: a retrospective comparison of routine echocardiography and invasive hemodynamics. J Am Soc Echocardiogr. 2013;26:457-63.
25. Marrone O, Bonsignore MR. Pulmonary haemodynamics in obstructive sleep apnoea. Sleep Med Rev. 2002;6:175-93.
26. Girard C, Fargnoli JM, Fourie P, Maitrasse B, Arvieux CC. Comparison between acute hypoxia-induced and mechanically-induced pulmonary artery hypertension on the hemodynamics, myocardial contractility and regional blood flow in dogs. Fundam Clin Pharmacol. 1995;9:554-61.
27. Coccagna G, Mantovani M, Brignani F, Parchi C, Lugaresi E. Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy). 1972;8:1159-72.
28. Lonsdorfer J, Meunier-Carus J, Lampert-Benignus E, Kurtz D, Bapst-Reiter J, Fletto R, et al. hemodynamic and respiratory aspects of the pickwickian syndrome. Bull Physiopathol Respir (Nancy). 1972;8:1181-92.
29. Bonsignore MR, Marrone O, Romano S, Pieri D. Time course of right ventricular stroke volume and output in obstructive sleep apneas. Am J Respir Crit Care Med. 1994;149:155-9.
30. Marrone O, Milone F, Ferrara G, Romano L, Bellia V. Transmural pulmonary artery pressure during cpap in obstructive sleep apnoea syndrome. Eur Respir J Suppl. 1990;11:544s-5.
31. Marrone O, Bellia V, Ferrara G, Milone F, Romano L, Salvaggio A, et al. Transmural pressure measurements. Importance in the assessment of pulmonary hypertension in obstructive sleep apneas. Chest. 1989;95:338-42.
32. Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest. 1996;109:380-6.
33. Weitzenblum E, Krieger J, Apprill M, Vallee E, Herhart M, Ratomaharo J, et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis. 1988;138:345-9.
34. Laks L, Lehrhaft B, Grunstein RR, Sullivan CE. Pulmonary hypertension in obstructive sleep apnoea. Eur Respir J. 1995;8:537-41.
35. Sanner B, Doberauer C, Konermann M, Sturm A, Zidek W. Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med. 1997;157:2483-7.
36. Niijima M, Kimura H, Edo H, Shinozaki T, Kang J, Masuyama S, et al. Manifestation of pulmonary hypertension during REM sleep in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1999;159:1766-72.
37. Bady E, Achkar A, Pascal S, Orvoen-Frija E, Laaban J-P. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax. 2000;55:934-9.
38. Minai OA, Ricaurte B, Kaw R, Hammel J, Mansour M, McCarthy K, et al. Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am J Cardiol. 2009;104:1300-6.
39. •• Dumitrascu R, Tiede H, Eckermann J, Mayer K, Reichenberger F, Ghofrani HA, et al. Sleep apnea in precapillary pulmonary hypertension. Sleep Med. 2013;14:247-51. This work demonstrated a surprising high prevalence of sleep disordered breathing (25 %) in patients with pulmonary hypertension.
40. Minai OA, Pandya CM, Golish JA, Avecillas JF, McCarthy K, Marlow S, et al. Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension. Chest. 2007;131:109-17.
41. Schulz R, Baseler G, Ghofrani HA, Grimminger F, Olschewski H, Seeger W. Nocturnal periodic breathing in primary pulmonary hypertension. Eur Respir J: Off J Eur Soc Clin Respir Physiol. 2002;19:658-63.
42. Ulrich S, Fischler M, Speich R, Bloch KE. Sleep-related breathing disorders in patients with pulmonary hypertension. Chest. 2008;133:1375-80.
43. Sajkov D, Wang T, Saunders NA, Bune AJ, McEvoy RD. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2002;165:152-8.
44. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Martinez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J. 2006;27:1106-13.